RecruitingNCT03588481
IRIS- DESyne X2 in the IRIS-DES Registry
Evaluation of Effectiveness and Safety of DESyne X2 in Routine Clinical Practice; A Multicenter, Prospective Observational Study
Sponsor
Seung-Jung Park
Enrollment
1,000 participants
Start Date
Nov 28, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Eligibility
Min Age: 19 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called DESyne X2 for people with coronary disease, coronary occlusion, and other related conditions. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 19 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDESyne X2
Novolimus-eluting stent
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03588481
Related Trials
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT072582902 locations
Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions
NCT067368999 locations
Evaluating New Radiation Techniques for Cardiovascular Imaging
NCT016215941 location
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
NCT076354071 location
Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque
NCT076604191 location